EZH2 and diffuse large B-cell lymphoma: Known mutations in DLBCL were also observed including MYD88 p.L265P (8%), EZH2 p.Y646F/N (9%), CARD11 p.D230N (4%) and CD79B p.Y196C (3%) (Table 1B).